Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic ChallengesMatteo Olivi, Marco Cerrano, Benedetto Bruno et al.|Current Treatment Options in Oncology|2023Cited by 20
Validation of <scp>SIE</scp>/<scp>SIES</scp>/<scp>GITMO</scp> consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclaxVincenzo Apolito, Felicetto Ferrara, Giulia Arrigo et al.|British Journal of Haematology|2023Cited by 6
PB2057: THE COMBINATION OF ANTI-COMPLEMENT THERAPY AND CYCLOSPORINE +/- ELTROMBOPAG IN PNH IS EFFECTIVE AND SAFE: A REAL-LIFE OBSERVATIONAL STUDY.Federica Catania, Valentina Giai, Chiara Frairia et al.|HemaSphere|2023Cited by 0
TREATMENT - CURRENT TREATMENT OPTIONS - HIGHER RISK MDSChiara Frairia, Ernesta Audisio, Federica Catania et al.|Leukemia Research|2025Cited by 0